Details for Patent: 10,792,447
✉ Email this page to a colleague
Which drugs does patent 10,792,447 protect, and when does it expire?
Patent 10,792,447 protects QVAR REDIHALER and is included in one NDA.
This patent has fourteen patent family members in nine countries.
Summary for Patent: 10,792,447
| Title: | Breath actuated inhaler |
| Abstract: | A breath actuated metered dose inhaler may include a canister fire system configured to fire a medicament containing canister in response to patient inhalation. The canister fire system may include a pneumatic force holding unit and having a rest configuration in which a metering valve of the canister is in a refill configuration; a prepared configuration in which a canister actuation force is retained by the pneumatic force holding unit and the canister fire system is actuatable by patient inhalation induced airflow; and a fire configuration in which the metering valve is in a dose delivery position. When in the prepared configuration, the force retained by the so pneumatic force holding unit may be reduced by less than about 6% over a period of 5 minutes, preferably less than about 3% over a period of 5 minutes. |
| Inventor(s): | Walsh; Declan (Waterford, IE), Prendergast; Paul (Waterford, IE), Buck; Daniel (Waterford, IE), Kent; Trevor (Waterford, IE), Thompson; Niall (Waterford, IE) |
| Assignee: | NORTON (WATERFORD) LIMITED (Waterford, IE) |
| Application Number: | 16/258,330 |
|
Patent Claim Types: see list of patent claims | Use; Delivery; Device; |
Drugs Protected by US Patent 10,792,447
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Norton Waterford | QVAR REDIHALER | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 207921-001 | Aug 3, 2017 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| Norton Waterford | QVAR REDIHALER | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 207921-002 | Aug 3, 2017 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 10,792,447
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| United Kingdom | 1801309.4 | Jan 26, 2018 |
International Family Members for US Patent 10,792,447
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Canada | 3089428 | ⤷ Try a Trial | |||
| China | 111818954 | ⤷ Try a Trial | |||
| European Patent Office | 3517155 | ⤷ Try a Trial | |||
| European Patent Office | 3998096 | ⤷ Try a Trial | |||
| European Patent Office | 4098301 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
